CXCR4 and cholangiocarcinoma: Taken together, SCLC, cholangiocarcinoma, highly dedifferentiated NEN, and ACC may be the most promising tumor entities for a CXCR4-directed PET (Fig. 2) [8, 19, 25, 29].